Cargando…
Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration
Intravitreal vascular endothelial growth factor (VEGF) receptor blockade is used for a variety of retinal pathologies. These include age-related macular degeneration (AMD), diabetic macular edema (DME) and central retinal vein obstruction. Reports of absorption of intravitreal agents into systemic c...
Autores principales: | Phadke, Gautam, Hanna, Ramy M, Ferrey, Antoney, Torres, Everardo Arias, Singla, Anjali, Kaushal, Amit, Kalantar-Zadeh, Kamyar, Kurtz, Ira, Jhaveri, Kenar D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483684/ https://www.ncbi.nlm.nih.gov/pubmed/34603693 http://dx.doi.org/10.1093/ckj/sfab066 |
Ejemplares similares
-
Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use
por: Hanna, Ramy M., et al.
Publicado: (2020) -
Refractory scleroderma renal crisis precipitated after high-dose oral
corticosteroids and concurrent intravitreal injection of
bevacizumab
por: Hanna, Ramy M, et al.
Publicado: (2020) -
Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020) -
Anaplastic lymphoma kinase inhibitors and their effect on the kidney
por: Bonilla, Marco, et al.
Publicado: (2022) -
Local anesthetics for the Nephrologist
por: Uppal, Nupur N, et al.
Publicado: (2021)